Aidea Pharma(SH:688488) Zheng Quan Zhi Xing·2025-07-21 09:17Core Viewpoint - Jiangsu Aidea Pharmaceutical Co., Ltd. has completed the registration of its name change to Jiangsu Aidea Pharmaceutical Group Co., Ltd. and has obtained a new business license [1] Group 1: Company Name Change - The company held its third board meeting and the second extraordinary shareholders' meeting on June 27 and July 14, 2025, respectively, where the proposal to change the company name was approved [1] - The English name has been changed from "Jiangsu Aidea Pharmaceutical Co., Ltd." to "Jiangsu Aidea Pharmaceutical Group Co., Ltd." [1] - The name change does not affect the stock abbreviation and stock code [1] Group 2: Business License and Registration - The company has completed the business registration change and obtained a new business license from the Yangzhou Market Supervision Administration [1] - The new business license details include: - Name: Jiangsu Aidea Pharmaceutical Group Co., Ltd. - Unified Social Credit Code: 913210006979433664 - Type: Joint-stock company (foreign investment, listed) - Legal Representative: Fu Helian - Registered Capital: 420.782808 million RMB - Establishment Date: December 15, 2009 - Address: No. 69, Xinganqian West Road, Hanjiang District, Yangzhou City [1] Group 3: Business Scope - The company's business scope includes drug research and development, production and sales, development, acquisition, processing, and sales of effective components from human urine protein, animal organs, and plant raw materials, as well as technology research and development, transfer, consulting, and services [1] - The company is also engaged in the import and export of general goods and technologies, subject to national regulations [1]